Berylson Capital Partners, LLC Invitae Corp Transaction History

Berylson Capital Partners, LLC

  • $40.7 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $2.63 Million - $3.63 Million
-108,000 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$26.09 - $40.4 $1.4 Million - $2.16 Million
-53,500 Reduced 33.13%
108,000 $3.64 Million
Q1 2021

May 17, 2021
BUY
$33.06 - $56.93 $1.88 Million - $3.25 Million
57,000 Added 54.55%
161,500 $6.17 Million
Q4 2020

Feb 16, 2021
BUY
$39.09 - $57.4 $4.08 Million - $6 Million
104,500 New
104,500 $4.37 Million

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Berylson Capital Partners, LLC Portfolio

Follow Berylson Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berylson Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Berylson Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email